Trial intelligence / Profile preview

Neoadjuvant Estradiol vs ADT in Localized Prostate Cancer

NCT00167648Phase 2Completed

Sponsor
University of Washington
Start
Mar 2005
Primary completion
Dec 2006
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in prostate cancer (PCa), sponsored by University of Washington. Started Mar 2005; status: completed.

02

Drugs

estradiol
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00167648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00167648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call